rs1921490

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001348800.3(ZBTB20):​c.-342-26915A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.959 in 152,148 control chromosomes in the GnomAD database, including 70,224 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.96 ( 70224 hom., cov: 31)

Consequence

ZBTB20
NM_001348800.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.633

Publications

0 publications found
Variant links:
Genes affected
ZBTB20 (HGNC:13503): (zinc finger and BTB domain containing 20) This gene, which was initially designated as dendritic cell-derived BTB/POZ zinc finger (DPZF), belongs to a family of transcription factors with an N-terminal BTB/POZ domain and a C-terminal DNA-bindng zinc finger domain. The BTB/POZ domain is a hydrophobic region of approximately 120 aa which mediates association with other BTB/POZ domain-containing proteins. This gene acts as a transcriptional repressor and plays a role in many processes including neurogenesis, glucose homeostasis, and postnatal growth. Mutations in this gene have been associated with Primrose syndrome as well as the 3q13.31 microdeletion syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2017]
ZBTB20 Gene-Disease associations (from GenCC):
  • Primrose syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001348800.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.991 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001348800.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZBTB20
NM_001348800.3
MANE Select
c.-342-26915A>G
intron
N/ANP_001335729.1Q9HC78-1
ZBTB20
NM_001348803.3
c.-465-26915A>G
intron
N/ANP_001335732.1Q9HC78-1
ZBTB20
NM_001393393.1
c.-343+25374A>G
intron
N/ANP_001380322.1Q9HC78-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZBTB20
ENST00000675478.1
MANE Select
c.-342-26915A>G
intron
N/AENSP00000501561.1Q9HC78-1
ZBTB20
ENST00000474710.6
TSL:1
c.-522-26915A>G
intron
N/AENSP00000419153.1Q9HC78-1
ZBTB20
ENST00000357258.8
TSL:1
c.-397-26915A>G
intron
N/AENSP00000349803.3Q9HC78-2

Frequencies

GnomAD3 genomes
AF:
0.959
AC:
145770
AN:
152030
Hom.:
70173
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.863
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.986
Gnomad ASJ
AF:
0.974
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.997
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.991
Gnomad NFE
AF:
0.997
Gnomad OTH
AF:
0.961
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.959
AC:
145879
AN:
152148
Hom.:
70224
Cov.:
31
AF XY:
0.961
AC XY:
71492
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.863
AC:
35788
AN:
41470
American (AMR)
AF:
0.987
AC:
15062
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.974
AC:
3381
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5178
AN:
5178
South Asian (SAS)
AF:
0.997
AC:
4814
AN:
4830
European-Finnish (FIN)
AF:
1.00
AC:
10612
AN:
10614
Middle Eastern (MID)
AF:
0.990
AC:
291
AN:
294
European-Non Finnish (NFE)
AF:
0.997
AC:
67808
AN:
67996
Other (OTH)
AF:
0.962
AC:
2033
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
275
550
824
1099
1374
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.940
Hom.:
25145
Bravo
AF:
0.954
Asia WGS
AF:
0.992
AC:
3450
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
6.0
DANN
Benign
0.37
PhyloP100
0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1921490;
hg19: chr3-114439337;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.